Evidence map›Paper›PMID 31324241›Full record

ArticleBMC complementary and alternative medicine2019

Pharmacy employees' involvement in safeguarding persons with dementia who use dietary supplements: Results from a survey of Norwegian pharmacies.

Hilde Risvoll, Frauke Musial, Kjell H Halvorsen, Trude Giverhaug, Marit Waaseth

Open access · goldAbstract read
In one paragraph

Article in BMC complementary and alternative medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.5field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Hilde RisvollNAFKAM, Institute for Community Medicine, UiT The Arctic University of Norway, pb 6050 Langnes, 9037, Tromsø, Norway. hilde.risvoll@uit.no.ORCID http://orcid.org/0000-0002-8954-0892
Frauke MusialNAFKAM, Institute for Community Medicine, UiT The Arctic University of Norway, pb 6050 Langnes, 9037, Tromsø, Norway.
Kjell H HalvorsenDepartment of Pharmacy, UiT The Arctic University of Norway, pb 6050 Langnes, 9037, Tromsø, Norway.
Trude GiverhaugRELIS North Norway, University Hospital of North Norway, Sykehusvegen 38, 9019, Tromsø, Norway.
Marit WaasethDepartment of Pharmacy, UiT The Arctic University of Norway, pb 6050 Langnes, 9037, Tromsø, Norway.
UiT The Arctic University of Norway · NONordic wildfish (Norway) · NOUniversity Hospital of North Norway · NO

Funding

Helse Nord RHF HST1310-15
6 · The paper itself

Abstract

backgroundCommunity-dwelling persons with dementia commonly use dietary supplements (DS), often without receiving help with the administration. Patient safety is a concern, as DS-drug interactions and adverse events are potential complications. Since many persons with dementia buy their DS in pharmacies, we investigated Norwegian pharmacy employees' attitudes and professional practice behaviors related to DS.

methodsWe conducted a survey in eight Norwegian municipalities of pharmacy employees involved in the sale of DS. The questionnaire covered demographics and investigated attitudes toward DS, professional practice behaviors related to the sale of DS, experiences with customers with dementia, and perceived and attributed responsibilities with regard to patient safety.

resultsOne hundred and five employees responded (response rate: 52%). Most employees regarded general practitioners (GPs) as primarily responsible for safeguarding the use of DS by persons with dementia and rated themselves less responsible. Thirty-seven percent of the employees reported personal use of DS (past or current use). Nine percent considered some of the DS to have symptomatic or prophylactic effects against dementia. Forty-eight percent confirmed that they informed customers about potential adverse events; 42% indicated that they did this sometimes. Sixteen percent checked regularly for DS-drug interactions, and two-thirds checked depending on the customers' health, the type of drug or the type of DS. One-quarter regularly asked about the co-use of prescription drugs (PD) when selling DS, while only 2% asked about the co-use of DS when dispensing PD. Only 25% reported access to independent scientific information on all or most DS sold in their pharmacy. Eight percent had experienced unsafe use of DS by persons with dementia. Six percent had been taught about counselling persons with dementia. Education level influenced professional practice behavior to some extent.

conclusionPharmacy employees do not see themselves as primarily responsible for the safe use of DS by persons with dementia. Moreover, they have limited experience with the unsafe use of DS by these persons. There is potential for improvement regarding tools and educational interventions for pharmacy employees to provide sufficient help to persons with dementia who use DS.

Indexed as

AdultAgedDementiaDietary SupplementsDrug InteractionsFemaleHealth Knowledge, Attitudes, PracticeHumansMaleMiddle AgedNorwayPharmacistsPharmacySurveys and QuestionnairesAttitudeAttributed responsibilityCross-sectional surveyDementiaDietary supplementsPatient safetyPharmacyProfessional practice behaviorRisk management

Identifiers

PMID31324241
PMCPMC6642513
OpenAlexW2963050074

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.